Cynthia Dwork, Ph.D. in the Field of Electronics, Information, and Communication Shizuo Akira, Ph.D. and Zhijian “James” Chen, Ph.D. in the Field of Life Science TOKYO–(BUSINESS WIRE)–The Japan Prize Foundation (President: Ryozo Nagai) held an award ceremony on Tuesday, April 14, at the New National Theatre, Tokyo in Tokyo’s Shibuya Ward to confer the Japan … [Read more…]
New data highlights strong contributions to rural health and underserved communities CHICAGO–(BUSINESS WIRE)–Newly released rankings from U.S. News & World Report underscore the significant role osteopathic medical schools play in preparing physicians to serve in high-need areas across the country. The latest data show that colleges of osteopathic medicine (COMs) continue to distinguish themselves in … [Read more…]
LONDON & NEW YORK–(BUSINESS WIRE)–$CMPS #Biotech–Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today an invitation for U.S. based organizations to apply for a grant to create training content for healthcare providers to deliver investigational COMP360 psilocybin treatment, if approved. Many high-quality training … [Read more…]
Funding to accelerate scale-up of world-leading Knowsley fermentation facility LONDON–(BUSINESS WIRE)–Clean Food Group, a leading UK biotech manufacturer pioneering sustainable oils and fats through fermentation, is pleased to confirm a £4.5 million investment led by Clean Growth Fund and New Agrarian, two specialist investors dedicated to fostering sustainable growth in food technology. CFG has also … [Read more…]
NEW YORK–(BUSINESS WIRE)–Anthem Blue Cross and Blue Shield in New York today announced a new three-year agreement with Mount Sinai Health System that returns its hospitals, physicians, and other care providers to Anthem’s network. The agreement keeps Mount Sinai care accessible for Anthem members and reflects both organizations’ commitment to delivering quality care while helping … [Read more…]
Daily April 14-17, Gilead HQ, 10:30 a.m. -11:30 a.m. HIV drug maker’s pricing for its lifesaving HIV drugs puts nation’s HIV safety nets under tremendous strain; one Gilead’s HIV medication, Biktarvy, carried an annual sticker price of nearly $61,000 per patient in 2025 SAN FRANCISCO–(BUSINESS WIRE)–#AHFcares–Advocates and mobilizers affiliated with AIDS Healthcare Foundation (AHF) will … [Read more…]
FILSPARI indicated to reduce proteinuria in adults and children aged 8 years and older with FSGS who do not have nephrotic syndrome Additional indication for FILSPARI expands total addressable population to more than 100,000 patients in the U.S, including more than 30,000 patients with FSGS Label aligns with KDIGO clinical practice guidelines for managing patients … [Read more…]
SALT LAKE CITY–(BUSINESS WIRE)–NomosLogic, Inc. today introduced its molecular medicine infrastructure platform, designed to transform raw genomic files into clinically actionable intelligence across pharmacogenomics, disease susceptibility, and systems-level health modeling. NomosLogic operates as an infrastructure layer for molecular medicine rather than a point product. Its integrated stack includes: TRINITY, a deterministic multi-omic fusion engine for … [Read more…]
Candice Stoner and Courtney Mueller join a decade-long legacy of TALA Hero Award recognition HOUSTON–(BUSINESS WIRE)–Belmont Village Senior Living proudly announces Candice Stoner, Executive Director at Belmont Village West Lake Hills and Courtney Mueller, Memory Program Director at Belmont Village West University, have been recognized with the prestigious Texas Assisted Living Association (TALA) Hero Award. … [Read more…]
Phase 1/2 RAINFOL™-01 data showed the combination of rinatabart sesutecan (Rina-S®) and bevacizumab was tolerable, with no new safety signals in patients with advanced ovarian cancer The ongoing Phase 3 RAINFOL-04 trial will further evaluate the combination in patients with recurrent platinum-sensitive ovarian cancer (PSOC) COPENHAGEN, Denmark–(BUSINESS WIRE)–Genmab A/S (Nasdaq: GMAB) announced today new data … [Read more…]
